Aaron J. Johnson Department of Immunology Mayo Clinic, Rochester Biography Publications Institution JoVE Articles Aaron J. Johnson has not added a biography. If you are Aaron J. Johnson and would like to personalize this page please email our Author Liaison for assistance. Publications Conditional Silencing of H-2D Class I Molecule Expression Modulates the Protective and Pathogenic Kinetics of Virus-Antigen-Specific CD8 T Cell Responses During Theiler's Virus Infection Journal of Immunology (Baltimore, Md. : 1950). Sep, 2020 | Pubmed ID: 32737149 Non-equivalent Antigen Presenting Capabilities of Dendritic Cells and Macrophages in Generating Brain-infiltrating CD8 T Cell Responses Nature Communications. Feb, 2018 | Pubmed ID: 29434238 Finding a Balance Between Protection and Pathology: The Dual Role of Perforin in Human Disease International Journal of Molecular Sciences. Jul, 2017 | Pubmed ID: 28757574 Perforin Expression by CD8 T Cells Is Sufficient To Cause Fatal Brain Edema During Experimental Cerebral Malaria Infection and Immunity. May, 2017 | Pubmed ID: 28264905 Brain Atrophy in Picornavirus-infected FVB Mice is Dependent on the H-2D Class I Molecule FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology. Jun, 2017 | Pubmed ID: 28188174 Superior Isolation of Antigen-specific Brain Infiltrating T Cells Using Manual Homogenization Technique Journal of Immunological Methods. Dec, 2016 | Pubmed ID: 27623324 Modulatory Effects of Perforin Gene Dosage on Pathogen-associated Blood-brain Barrier (BBB) Disruption Journal of Neuroinflammation. Aug, 2016 | Pubmed ID: 27576583 Improved Treatment Efficacy of Antiangiogenic Therapy when Combined with Picornavirus Vaccination in the GL261 Glioma Model Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics. Jan, 2016 | Pubmed ID: 26620211 Quantitative Trait Loci Analysis Reveals Candidate Genes Implicated in Regulating Functional Deficit and CNS Vascular Permeability in CD8 T Cell-initiated Blood--brain Barrier Disruption BMC Genomics. Oct, 2013 | Pubmed ID: 24090483 Évaluation des toxicités associées aux lymphocytes T du récepteur de l’antigène chimérique à l’aide d’un modèle murin xénogreffé dérivé d’un patient atteint de leucémie lymphoblastique aiguë Claudia Manriquez Roman1,2,3,4,5, R. Leo Sakemura1,2, Brooke L. Kimball1,2, Fang Jin6, Roman H. Khadka6, Mohamad M. Adada1,2, Elizabeth L. Siegler1,2, Aaron J. Johnson6, Saad S. Kenderian1,2,6 1T Cell Engineering Laboratory, Mayo Clinic, Rochester, 2Division of Hematology, Mayo Clinic, Rochester, 3Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, 4Department of Molecular Medicine, Mayo Clinic, Rochester, 5Regenerative Sciences PhD Program, Mayo Clinic, Rochester, 6Department of Immunology, Mayo Clinic, Rochester JoVE 64535 Cancer Research
Évaluation des toxicités associées aux lymphocytes T du récepteur de l’antigène chimérique à l’aide d’un modèle murin xénogreffé dérivé d’un patient atteint de leucémie lymphoblastique aiguë Claudia Manriquez Roman1,2,3,4,5, R. Leo Sakemura1,2, Brooke L. Kimball1,2, Fang Jin6, Roman H. Khadka6, Mohamad M. Adada1,2, Elizabeth L. Siegler1,2, Aaron J. Johnson6, Saad S. Kenderian1,2,6 1T Cell Engineering Laboratory, Mayo Clinic, Rochester, 2Division of Hematology, Mayo Clinic, Rochester, 3Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, 4Department of Molecular Medicine, Mayo Clinic, Rochester, 5Regenerative Sciences PhD Program, Mayo Clinic, Rochester, 6Department of Immunology, Mayo Clinic, Rochester JoVE 64535 Cancer Research
